Drug prices and trends for SM ENEMA READY TO USE

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
SM ENEMA READY TO USE	49348-0186-20	0.00657	ML	2026-03-18
SM ENEMA READY TO USE	49348-0186-20	0.00653	ML	2026-02-18
SM ENEMA READY TO USE	49348-0186-20	0.00648	ML	2026-01-21
SM ENEMA READY TO USE	49348-0186-20	0.00629	ML	2025-12-17
SM ENEMA READY TO USE	49348-0186-20	0.00652	ML	2025-11-19
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Last updated: March 11, 2026

What is the Current Market Position of SM ENEMA READY TO USE?

SM ENEMA READY TO USE is a prepackaged docusate sodium enema designed for constipation relief. It targets adult and pediatric populations needing an over-the-counter (OTC) bowel regulation solution. The drug's formulation allows for easy administration without the need for mixing or preparation.

Product Features

Formulation: Ready-to-use enema
Active Ingredient: Docusate sodium
Volume per unit: 118 mL
Application: Rectal administration
Packaging: Single-use plastic tube
Indications: Short-term relief for occasional constipation

Market Segment

The product belongs to the OTC laxative market, specifically the enema segment. Competitors include fleets of similar prefilled enemas, such as Fleet's (brand name) and generic equivalents.

Regulatory Status

The drug holds OTC approval in the United States via the Food and Drug Administration (FDA). It follows the monograph route, which simplifies regulatory pathways for OTC products.

What Are the Market Dynamics and Trends?

Historical Market Data Overview

The global enema market was valued at approximately $400 million in 2021.
The OTC laxative segment constitutes around 70% of this market.
The segment experienced Compound Annual Growth Rate (CAGR) of 4% from 2016 to 2021.

Drivers

Increasing prevalence of constipation due to aging populations and lifestyle factors.
Growing consumer preference for OTC solutions over prescribed medications.
Rising awareness about constipation management and self-care options.
Convenience of ready-to-use formulations over traditional bulk solutions.

Challenges

Market saturation with existing products.
Regulatory hurdles for new delivery forms.
Competition from prescription laxatives and newer drug classes such as prokinetics.

Price Projections and Market Entry Strategies

Current Pricing Landscape

Average retail price (ARP) for a 118 mL prefilled enema ranges from $8 to $15 per unit.
Discounted OTC prices, typically sold in pharmacies and online: approximately $7–$12 per unit.
Generics typically priced 10–20% lower than patented brands.

Brand Name/Product	Retail Price (USD)	Packaging/ Volume	Market Position
Fleet Enema	$9.99	4 oz (118 mL)	Market leader, premium
Generic equivalents	$7–$8	4 oz	Price-sensitive segment
SM ENEMA READY TO USE	Estimated $9–$11	4 oz	Potential new entrant

Price Projection (Next 3-5 Years)

Year 1 (Launch): $9–$11, targeting existing OTC buyers.
Year 2: Slight reduction to $8–$10 to attract price-sensitive consumers and compete with generics.
Year 3–5: Stabilization at $8–$9, assuming no regulatory or patent changes, with potential for slight discounts/promotions.

Revenue Estimates

Assuming an initial market share capturing 5% of the enema segment (~$28 million in 2021 dollars), annual sales could range from $1.4 million to $2.8 million at launch.
Market share expansion depends on marketing effectiveness, distribution channels, and physician endorsement.

Market Entry and Growth Strategies

Pricing Strategy: Competitive pricing around $8–$9 to gain quick adoption.
Distribution: Pharmacies, big-box retailers, online platforms.
Marketing: Emphasize ease of use, safety profile, and OTC status.
Regulatory: Leverage OTC monograph to minimize regulatory delays.

Key Market Considerations for Investors and R&D

The enema market growth driven by aging demographics and lifestyle-induced constipation.
Competitive pressure from both branded and private-label generic products.
Potential for premium pricing if marketed with added features (e.g., organic, fluoride-free).

Key Takeaways

The global enema market was valued at ~$400 million in 2021, with the OTC segment comprising 70%.
Existing prices range from $7 to $15 per unit, with Fleet Enema as a market leader at about $10.
Market entry price for SM ENEMA READY TO USE is projected at ~$9–$11, with stabilization around $8–$9.
Revenue potential depends heavily on market share gains and distribution channels.
Ongoing demographic trends favor market expansion, but intense competition and regulatory dynamics influence pricing strategies.

FAQs

1. How does SM ENEMA READY TO USE differ from existing products?
It emphasizes convenience with premeasured, ready-to-use packaging, targeting consumers seeking quick, mess-free bowel relief.

2. What are regulatory barriers?
As an OTC monograph drug, the product faces minimal regulatory hurdles, primarily related to manufacturing compliance and labeling.

3. How sensitive is the market to pricing changes?
Price sensitivity influences consumer choice heavily in OTC segments. Slight reductions can significantly affect market share.

4. What are the main competitors?
Fleet Enema and various generics dominate the market with established brands and lower-priced options.

5. Is there growth potential?
Yes. The aging population and increased awareness of self-care contribute to sustained demand, provided the product maintains competitive pricing and distribution.

References

[1] MarketWatch. (2022). Enema Market Size, Share, Growth. https://www.marketwatch.com/
[2] Research and Markets. (2021). Global OTC Laxative Market Report. https://www.researchandmarkets.com/
[3] U.S. Food and Drug Administration. (2022). OTC Monographs. https://www.fda.gov/

Note: Data points derived from public sources; actual figures subject to market fluctuations.

Drug Price Trends for SM ENEMA READY TO USE

Average Pharmacy Cost for SM ENEMA READY TO USE

Market Analysis and Price Projections for SM ENEMA READY TO USE